ACTHar in the Treatment of Lupus Nephritis

NCT02226341 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Lupus Nephritis

Interventions

DRUG: CellCept
DRUG: ACTHar gel

Sponsor

Columbia University